Previous close | 10.40 |
Open | 9.80 |
Bid | 9.90 x N/A |
Ask | 10.50 x N/A |
Day's range | 9.75 - 9.80 |
52-week range | 9.25 - 21.80 |
Volume | |
Avg. volume | 36 |
Market cap | 6.654B |
Beta (5Y monthly) | 0.78 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 26 July 2024 - 30 July 2024 |
Forward dividend & yield | 0.26 (2.47%) |
Ex-dividend date | 28 Mar 2024 |
1y target est | N/A |
M3 Wake Research, a leading fully integrated network of clinical research sites and one of North America's largest providers of Phase I-IV clinical trials, is expanding operations into Charleston, SC with the opening of a clinical research practice. Operating as Charleston Clinical Trials, LLC, the new center is led by Donald Hurley, DO, and located at 2270 Ashley Crossing Drive in Charleston.